Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus

SIMPLE SUMMARY: Gliomas account for 27% of all primary central nervous system tumors and have a highly aggressive growth pattern, leading most patients to be insensitive to conventional treatment. Viotherapy as a progressive therapeutic tool may be beneficial to improve the outcome of brain tumor tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kangyixin, Shi, Xiangwei, Li, Li, Nie, Xiupeng, Xu, Lin, Jia, Fan, Xu, Fuqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571546/
https://www.ncbi.nlm.nih.gov/pubmed/37835433
http://dx.doi.org/10.3390/cancers15194738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571546/
https://www.ncbi.nlm.nih.gov/pubmed/37835433
http://dx.doi.org/10.3390/cancers15194738

Ejemplares similares